Beta-3 receptor ligands and their use in therapy
AssigneeUniversita' Degli Studi Di Bari
InventorsAntonio Scilimati, Maria Grazia Perrone, Ernesto Santandrea
Life of this patent
Estimating the term…
Abstract
The present invention relates to new compounds, ligands of the beta-3 adrenergic receptor, their preparation and their use in therapy or as research tools for said receptor; the invention also relates to a process for the preparation of the compounds of the invention and the use of inverse agonists of the beta-3 adrenergic receptor as medicaments.
Claims32
A compound of formula (I)
- wherein:
- R represents a hydrogen atom, a hydroxyl group, an alkoxyl group, an alkyl group, a carbaldoxime group or a halogen atom;
- R1 represents a hydrogen atom or a methyl group;
- R2 represents a hydrogen atom, a hydroxyl group, an alkoxyl group, an alkyl group or a halogen atom;
- R3, R4 each independently represents an alkyl group or R3 represents an atom of hydrogen and R4 is an alkyl group;
- R5 represents a hydrogen atom or an alkyl group;
- and its salts and solvates.
A compound of formula (II)
- wherein
- Y is CH or N;
- Z is a direct bond or a —O—CH2— group wherein the oxygen atom is bound to the ring;
- n is 0, 1 or 2, provided that when n is 1 or 2, X is N and when n is 0, X is NH, O or S;
- R6 is a hydrogen atom, an alkyl group, an optionally substituted aryl group, a optionally substituted heteroaryl group, a halogen atom, —OH, NH2, —O-alkyl, optionally substituted-O-aryl, optionally substituted-O-heteroaryl, —NH—CO—R8, -optionally substituted —NH—CO-aryl, optionally substituted —NH—CO-heteroaryl, —NH—SO2-alkyl, optionally substituted NH—SO2-aryl, optionally substituted —NH—SO2-heteroaryl, —NH—SO2—R8, a nitro group;
- or when Y is CH, R6 is an aromatic group or heteroaromatic fused with the benzene ring to form a naphthalene or carbazole group;
- R7 is R8SO2—, optionally substituted R8CO—, —CO-aryl, optionally substituted —CO-heteroaryl, optionally substituted —SO2-aryl, optionally substituted —SO2-heteroaryl;
- R8 is an alkyl group;
- and its salts and solvates.
Use of a compound as inverse agonist of the beta-3 adrenergic receptor for the preparation of a medicament for the treatment of metabolic syndrome, cachexia and heart failure.
Dependencies are inferred from the claim text.